Temporal Variations in the Hepatitis C Virus Intrahost Population during Chronic Infection

ABSTRACT The intrahost evolution of hepatitis C virus (HCV) holds keys to understanding mechanisms responsible for the establishment of chronic infections and to development of a vaccine and therapeutics. In this study, intrahost variants of two variable HCV genomic regions, HVR1 and NS5A, were sequenced from four treatment-naïve chronically infected patients who were followed up from the acute stage of infection for 9 to 18 years. Median-joining network analysis indicated that the majority of the HCV intrahost variants were observed only at certain time points, but some variants were detectable at more than one time point. In all patients, these variants were found organized into communities or subpopulations. We hypothesize that HCV intrahost evolution is defined by two processes: incremental changes within communities through random mutation and alternations between coexisting communities. The HCV population was observed to incrementally evolve within a single community during approximately the first 3 years of infection, followed by dispersion into several subpopulations. Two patients demonstrated this pattern of dispersion for the rest of the observation period, while HCV variants in the other two patients converged into another single subpopulation after ∼9 to 12 years of dispersion. The final subpopulation in these two patients was under purifying selection. Intrahost HCV evolution in all four patients was characterized by a consistent increase in negative selection over time, suggesting the increasing HCV adaptation to the host late in infection. The data suggest specific staging of HCV intrahost evolution.

[1]  X. Forns,et al.  Virology and pathogenesis of hepatitis C virus recurrence , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[2]  J. Ajioka,et al.  Lack of polymorphism on the Drosophila fourth chromosome resulting from selection. , 1991, Genetics.

[3]  M E J Newman,et al.  Community structure in social and biological networks , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. Thomas,et al.  Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients , 1998, Hepatology.

[5]  M. Nei,et al.  Mathematical model for studying genetic variation in terms of restriction endonucleases. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[6]  H. Blum,et al.  Absence of viral escape within a frequently recognized HLA-A26-restricted CD8+ T-cell epitope targeting the functionally constrained hepatitis C virus NS5A/5B cleavage site. , 2007, The Journal of general virology.

[7]  C. Trautwein,et al.  Treatment of acute hepatitis C with interferon alfa-2b. , 2001, The New England journal of medicine.

[8]  N. Gruener,et al.  Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. , 2003, Gastroenterology.

[9]  M. Houghton,et al.  Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Laurent Excoffier,et al.  Arlequin (version 3.0): An integrated software package for population genetics data analysis , 2005, Evolutionary bioinformatics online.

[11]  T. Wright,et al.  Trends for genetic variation of Hepatitis C Virus quasispecies in Human Immunodeficiency virus-1 coinfected patients. , 2007, Virus research.

[12]  Paul E. Turner,et al.  Prisoner's dilemma in an RNA virus , 1999, Nature.

[13]  H. Thomas,et al.  Sequence variation in the large envelope glycoprotein (E2/NS1) of hepatitis C virus during chronic infection. , 1993, The Journal of infectious diseases.

[14]  C. Rice,et al.  Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. , 2007, Gastroenterology.

[15]  N. Saitou,et al.  The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.

[16]  J. Felsenstein Evolutionary trees from DNA sequences: A maximum likelihood approach , 2005, Journal of Molecular Evolution.

[17]  J. Margolick,et al.  Human Immunodeficiency Virus Type 1 Population Genetics and Adaptation in Newly Infected Individuals , 2008, Journal of Virology.

[18]  H. Bandelt,et al.  Median-joining networks for inferring intraspecific phylogenies. , 1999, Molecular biology and evolution.

[19]  M A Gerber,et al.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. , 1992, The New England journal of medicine.

[20]  Sergei L. Kosakovsky Pond,et al.  HyPhy: hypothesis testing using phylogenies , 2005, Bioinform..

[21]  Ziheng Yang,et al.  Estimating the distribution of selection coefficients from phylogenetic data with applications to mitochondrial and viral DNA. , 2003, Molecular biology and evolution.

[22]  M. Ait-goughoulte,et al.  Antibody-Dependent Enhancement of Hepatitis C Virus Infection , 2007, Journal of Virology.

[23]  Hui Li,et al.  Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection , 2008, Proceedings of the National Academy of Sciences.

[24]  David Posada,et al.  MODELTEST: testing the model of DNA substitution , 1998, Bioinform..

[25]  Piotr Formanowicz,et al.  Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy , 2010, Archives of Virology.

[26]  C. G. Wu,et al.  Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma , 2007, Proceedings of the National Academy of Sciences.

[27]  J. Heathcote,et al.  Treatment of hepatitis C , 2005, Journal of viral hepatitis.

[28]  R. S. Ross,et al.  Risk of hepatitis C virus transmission from an infected gynecologist to patients: results of a 7-year retrospective investigation. , 2002, Archives of internal medicine.

[29]  D. Finzi,et al.  Defective Virus Drives Human Immunodeficiency Virus Infection, Persistence, and Pathogenesis , 2006, Clinical and Vaccine Immunology.

[30]  M. Brook,et al.  Treatment of hepatitis. , 1988, The Journal of hospital infection.

[31]  L. Ravà,et al.  Occupational hepatitis C virus infection in Italian health care workers. Italian Study Group on Occupational Risk of Bloodborne Infections. , 1995, American journal of public health.

[32]  B. McMahon,et al.  Hepatitis C virus dynamics during natural infection are associated with long-term histological outcome of chronic hepatitis C disease. , 2007, The Journal of infectious diseases.

[33]  R. Thimme,et al.  Regulatory T cells in viral hepatitis. , 2007, World journal of gastroenterology.

[34]  G. Lauer,et al.  Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C , 2005, Hepatology.

[35]  F. Chisari,et al.  Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus andHost , 2006, Journal of Virology.

[36]  S. Sauleda,et al.  Effect of Bottlenecking on Evolution of the Nonstructural Protein 3 Gene of Hepatitis C Virus during Sexually Transmitted Acute Resolving Infection , 2005, Journal of Virology.

[37]  M. Salemi,et al.  Comparative rates of nucleotide sequence variation in the hypervariable region of E1/E2 and the NS5b region of hepatitis C virus in patients with a spectrum of liver disease resulting from a common source of infection. , 2002, Virology.

[38]  R. Purcell,et al.  A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. , 1996, Virology.

[39]  R. Esteban,et al.  Epidemiology of hepatitis C virus infection. , 1993, Journal of hepatology.

[40]  K. Crandall,et al.  Intraspecific gene genealogies: trees grafting into networks. , 2001, Trends in ecology & evolution.

[41]  B. Charlesworth,et al.  The pattern of neutral molecular variation under the background selection model. , 1995, Genetics.

[42]  Mark Harris,et al.  Hepatitis C virus NS5A: tales of a promiscuous protein. , 2004, The Journal of general virology.

[43]  Sergei L. Kosakovsky Pond,et al.  Not so different after all: a comparison of methods for detecting amino acid sites under selection. , 2005, Molecular biology and evolution.

[44]  J. Margolick,et al.  Consistent Viral Evolutionary Changes Associated with the Progression of Human Immunodeficiency Virus Type 1 Infection , 1999, Journal of Virology.

[45]  H. Chu,et al.  Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants , 2009, Journal of Virology.

[46]  Thomas Francis,et al.  EPIDEMIOLOGIC AND IMMUNOLOGIC SIGNIFICANCE OF AGE DISTRIBUTION OF ANTIBODY TO ANTIGENIC VARIANTS OF INFLUENZA VIRUS , 1953, The Journal of experimental medicine.

[47]  Rolf M. Zinkernagel,et al.  Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes , 1998, Nature.

[48]  Alan R Templeton,et al.  The reality and importance of founder speciation in evolution. , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.

[49]  D. Morrison,et al.  Using data-display networks for exploratory data analysis in phylogenetic studies. , 2010, Molecular biology and evolution.

[50]  P. Klenerman,et al.  CD4+ T cell responses in hepatitis C virus infection. , 2007, World journal of gastroenterology.

[51]  James J Goedert,et al.  HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. , 2005, Blood.

[52]  J. Lara,et al.  Coordinated evolution of the hepatitis C virus , 2008, Proceedings of the National Academy of Sciences.

[53]  Susan Moir,et al.  B cells in HIV infection and disease , 2009, Nature Reviews Immunology.

[54]  Darius Moradpour,et al.  Structural biology of hepatitis C virus. , 2003, Clinics in liver disease.

[55]  E. Shin,et al.  Private aspects of heterologous immunity , 2005, The Journal of experimental medicine.

[56]  Sumathi Ramachandran,et al.  End-point limiting-dilution real-time PCR assay for evaluation of hepatitis C virus quasispecies in serum: performance under optimal and suboptimal conditions. , 2008, Journal of virological methods.

[57]  F. Poordad,et al.  Treatment of hepatitis C , 2003 .